Peripheral Arterial Disease Trial, Recruiting NCT06573554 Sponsor: Post Graduate Institute of Medical Education and Research, Chandigarh Condition: Peripheral Arterial Disease
Back to Peripheral Arterial Disease

Peripheral Arterial Disease Trial, Recruiting

NCT06573554
Recruiting Not Applicable

Who may be able to join

AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI

Who might be able to join this trial:

  • People who have been diagnosed with Type 2 Diabetes.
  • People who have swelling in one foot (not both).
  • People who have an active condition called Charcot Neuroarthropathy, which is a serious condition affecting the bones and joints of the foot, often linked to diabetes-related nerve damage.
  • People who are 18 years of age or older.
  • People who are able to give their informed consent to participate.

Who may not be able to join:

  • People who have an open wound or ulcer on their foot.
  • People who have osteoporosis, measured by a bone density score (T score) lower than -2.5 at the lower spine or hip.
  • People who have gout.
  • People who have an active stomach ulcer or peptic ulcer disease.
  • People who have taken steroid medications within the last three months.
  • People whose kidneys are not working well enough, based on a specific kidney function measurement (confirm with trial site for the exact threshold).
  • People who have active tooth decay or who have recently had or are due to have an invasive dental procedure.
  • People who have poor blood flow in the legs and feet, based on a blood pressure measurement taken at the ankle (confirm with trial site for the exact threshold).
  • People who have swelling or involvement affecting both feet.
  • People who are pregnant or breastfeeding.
  • People who have received certain bone-protective medications (called antiresorptive agents) within the past 12 months.
  • People who do not wish to give their consent to participate.

Important: Always verify eligibility with the trial site directly before applying.

Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.

This is a simplified plain English summary of the eligibility criteria. Full criteria are set by the trial investigators and may include additional requirements not shown here. Never self-exclude from a trial based on this summary. Contact the trial site directly to confirm your eligibility.
Last synced 27 July 2026
This study is not part of the standard drug-approval phase pathway (for example an observational, device, behavioural, or registry study), so a phase success rate does not apply.

Contact this trial

Principal Investigator: Ashu Rastogi, DM MD, PGIMER, India

Phone: 9781001046

Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.

GP referral letter

Print a one-page summary to share with your doctor.

Trial details

Status
Recruiting
Phase
Not Applicable
Sponsor
Post Graduate Institute of Medical Education and Research, Chandigarh
Registry
ClinicalTrials.gov
Start date
11 December 2024
Est. completion
30 October 2026

Where this trial is recruiting

🇮🇳 India

Primary endpoints

Efficacy of posterior Slab

Can't join this trial?

Expanded access pathways

If this trial is not available to you, other access pathways may exist. In Australia, the TGA Special Access Scheme allows access to unapproved therapeutic goods for individual patients.

TGA Special Access Scheme information

Find other recruiting trials on ClinicalTrials.gov

Data last synced from ClinicalTrials.gov: 27 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.

Trial recruitment status can change without notice between our nightly data updates. Always contact the trial site directly to confirm current recruitment status before making any decisions or travel arrangements.

View original record on ClinicalTrials.gov